Skip to main content

Advertisement

Log in

Immunization status in children with inflammatory bowel disease

  • Original Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Inflammatory bowel diseases have an increased risk of infections due to immunosuppressive therapies. To report the immunization status according to previous recommendations and the reasons explaining a delay, a questionnaire was filled in by the pediatric gastroenterologist, concerning outpatients, in six tertiary centers and five local hospitals, in a study, from May to November 2011. One hundred and sixty-five questionnaires were collected, of which 106 Crohn's diseases, 41 ulcerative colitis, and 17 indeterminate colitis. Sex ratio was 87:78 M/F. Median age was 14.4 years old (4.2–20.0). One hundred and nine patients (66 %) were receiving or had received an immunosuppressive therapy (azathioprine, infliximab, methotrexate, or prednisone). Vaccines were up to date according to the vaccine schedule of French recommendations in 24 % of cases and according to the recommendations for inflammatory bowel disease in 4 % of cases. Coverage by vaccine was the following: diphtheria–tetanus–poliomyelitis 87 %, hepatitis B 38 %, pneumococcus 32 %, and influenza 22 %. Immunization delay causes were as follows: absence of proposal 58 %, patient refusal 41 %, fear of side effects 33 %, and fear of disease activation 5 %. Therefore, immunization coverage is insufficient in children with inflammatory bowel disease, due to simple omission or to refusal. A collaboration with the attending physicians and a targeted information are necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Beck F., Guilbert P., Gautier A. (dir.) (2007). Baromètre santé 2005 Attitudes et comportements de santé. Saint-Denis, INPES, coll. Baromètres santé, 279–296

  2. Crawford N, Buttery J (2010). Immunizations in an adolescent with inflammatory bowel disease. Paediatrics and Child Health 21:146–147. http://dx.doi.org/10.1016/j.paed.2010.09.007

    Google Scholar 

  3. Crawford NW, Gatto-Smith AG, Oliver MR, Cameron DJ, Buttery JP (2011) An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease. BMC Gastroenterol 11:87

    Article  PubMed Central  PubMed  Google Scholar 

  4. Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T (2010) Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis 16:347–353

    Article  PubMed  Google Scholar 

  5. Guthmann JP, Fonteneau L, Lévy-Bruhl D (2012). Mesure de la couverture vaccinale en France. Sources de données et données actuelles. Saint-Maurice: Institut de Veille Sanitaire; 98 p. http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies-infectieuses/2012/Mesure-de-la-couverture-vaccinale-en-France

  6. Haut Conseil de Santé Publique (France) (2012). Le calendrier des vaccinations et les recommandations vaccinales 2012 selon l'avis du Haut Conseil de la santé publique. BEH 14–15:161–187. http://www.invs.sante.fr/Publications-et-outils/BEH-Bulletin-epidemiologique-hebdomadaire/Derniers-numeros-et-archives/Archives/2012/BEH-n-14-15-2012

  7. Haut Conseil de Santé Publique (2012). Avis relatif aux recommandations vaccinales spécifiques des personnes immunodéprimées ou aspléniques. http://www.hcsp.fr/docspdf/avisrapports/hcspa20120216_recovaccimmuno.pdf

  8. Lichtenstein GR, Hanauer SB, Sandborn WJ, Practice Parameters Committee of the American College of Gastroenterology (2009) Management of Crohn's disease in adults. Am J Gastroenterol 104:465–483

    Article  PubMed  Google Scholar 

  9. Melmed GY, Ippoliti AF, Papadakis AK, Tran TT, Birt JL, Lee SK, Frenck RW, Targan SR, Vasiliauskas EA (2006) Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 101:1834–1840

    Article  PubMed  Google Scholar 

  10. Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N (2009) Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 360:1981–1988

    Article  CAS  PubMed  Google Scholar 

  11. Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, Domènech E, Eliakim R, Eser A, Frater J, Gassull M, Giladi M, Kaser A, Lémann M, Moreels T, Moschen A, Pollok R, Reinisch W, Schunter M, Stange EF, Tilg H, Van Assche G, Viget N, Vucelic B, Walsh A, Weiss G, Yazdanpanah Y, Zabana Y, Travis SP, Colombel JF, European Crohn's Colitis Organisation (ECCO) (2009) European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 3:47–91

    Article  CAS  PubMed  Google Scholar 

  12. Rahier JF, Moutschen M, Van Gompel A, Van Ranst M, Louis E, Segaert S, Masson P, De Keyser F (2010) Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology 49:1815–1827

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Rubin GP, Hungin APS, Kelly PJ, Ling J (2000) Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 14:1553–1559

    Article  CAS  PubMed  Google Scholar 

  14. Rufo PA, Denson LA, Sylvester FA, Szigethy E, Sathya P, Lu Y, Wahbeh GT, Sena LM, Faubion WA (2012) Health supervision in the management of children and adolescents with inflammatory bowel disease—recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 55(1):93–108

    Article  PubMed Central  PubMed  Google Scholar 

  15. Sands BE, Cuffari C, Katz J, Kugathasan S, Onken J, Vitek C, Orenstein W (2004) Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 10:677–692

    Article  PubMed  Google Scholar 

  16. Selby L, Hoellein A, Wilson JF (2011) Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients? Dig Dis Sci 56:819–824

    Article  PubMed  Google Scholar 

  17. Smith C (2006) Vaccination in Australia. Lancet 367:1575

    Article  PubMed  Google Scholar 

  18. Soons S, deBruyn JC, Wrobel I (2013) Immunization history of children with inflammatory bowel disease. Can J Gastroenterol 27:213–216

    Google Scholar 

  19. Stone MA, Mayberry JF, Baker R (2003) Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol 15:1275–1280

    Article  CAS  PubMed  Google Scholar 

  20. Teich N, Klugmann T, Tiedemann A, Holler B, Mössner J, Liebetrau A, Schiefke I (2011) Vaccination coverage in immunosuppressed patients: results of a regional health services research study. Dtsch Arztebl Int 108:105–111

    PubMed Central  PubMed  Google Scholar 

  21. Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ (2008) Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterol 134:929–936

    Article  Google Scholar 

  22. Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF (2008) Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 57:549–558

    Article  CAS  PubMed  Google Scholar 

  23. Wasan SK, Baker SE, Skolnik PR, Farraye FA (2010) A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol 105:1231–1238

    Article  PubMed  Google Scholar 

  24. Waters O, Ahmad T (2011) Opportunistic infections and vaccinations in IBD patients. J Crohns Colitis 5:263, author reply 264

    Article  PubMed  Google Scholar 

  25. Wilckens V, Kannengiesser K, Hoxhold K, Frenkel C, Kucharzik T, Maaser C (2011) The immunization status of patients with IBD is alarmingly poor before the introduction of specific guidelines. Scand J Gastroenterol 46:855–861

    Article  PubMed  Google Scholar 

  26. Yeung JH, Goodman KJ, Fedorak RN (2012) Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients. Inflamm Bowel Dis 18:34–40

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Jean‐Francois Segura, Laure Bridoux, Gaelle Le Henaff, Benoit Cagnard, Agathe Jobert, Joel Cardonna, Isabelle Grimal, Martine Balençon, Estelle Darviot, Nadege Delaperrière, Dominique Caldari and Hugues Piloquet are responsible for patient screening and enrollment.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Romain Longuet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Longuet, R., Willot, S., Giniès, JL. et al. Immunization status in children with inflammatory bowel disease. Eur J Pediatr 173, 603–608 (2014). https://doi.org/10.1007/s00431-013-2207-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-013-2207-0

Keywords

Navigation